Peptides DB

Research-centric peptide and protocol reference hub

Ipamorelin

Research-centric overview

Share
Peptide

Summary not yet generated. The Librarian will pick this up on the next daily run (12:00 UTC).

Community effect votes, structured logs, and side-effect summaries.

Effect profile (overview)

Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.

Effect profile (AI + community): Muscle & body comp 4.0/5 · Metabolic & appetite 2.0/5 · Sleep & circadian 2.0/5Healing 0.0Muscle 4.0Metabolic 2.0Neuro 0.0Sleep 2.0Inflammation 0.0Skin 0.0

Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.

Research footprint

Last analyzed Apr 17, 2026
4
Studies indexed
0
Human
3
Animal
3
AI analyzed
Evidence mix0% human · 75% animal · 0% cellular · 0% review
Highest phase: PreclinicalYears covered: 2020
Librarian pulse — latest actionsFull changelog ↓
  • Apr 17, 12:04 PMRefreshedRefreshed content for Ipamorelin
  • Apr 16, 5:13 PMRefreshedRefreshed content for Ipamorelin
  • Apr 16, 5:13 PMRefreshedRefreshed content for Ipamorelin

Research & intelligence feed

Studies, clinical trials, community discussions, and news.

Refreshed content for Ipamorelinai_activityai-researcherApr 17, 2026

Pulled 4 linked studies for context.

No external link
Refreshed content for Ipamorelinai_activityai-researcherApr 16, 2026

Pulled 4 linked studies for context. - **content** added: Body content generated (1387 chars).

No external link
Refreshed content for Ipamorelinai_activityai-researcherApr 16, 2026

Pulled 4 linked studies for context. - **content** added: Body content generated (1382 chars).

No external link
Phase II Double-Blind Placebo-Controlled Dose Finding Study to Evaluate Safety/Efficacy of Ipamorelin Compared to Placebo for Recovery of Gastrointestinal Function in Patients Following Small or Large Bowel Resection w/Primary AnastomosisClinical TrialClinicalTrials.govApr 16, 2026

This study evaluated the safety and efficacy of Ipamorelin compared to placebo for recovery of gastrointestinal function in patients following bowel resection with primary anastomosis. The specific dose and outcomes were not detailed in the abstract. The findings may inform future research directions in postoperative recovery.

Phase: PHASE2Status: COMPLETED
A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in PatientsClinical TrialClinicalTrials.govApr 16, 2026

This study evaluated the safety and efficacy of Ipamorelin compared to placebo for managing post-operative ileus in patients. The specifics regarding the dose and outcomes were not detailed in the abstract. The study is classified as a Phase II trial.

Phase: PHASE2Status: COMPLETED
Semantic Scholar search for IpamorelinStudySemanticScholarDec 12, 2025
Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.StudyPubMedDec 12, 2025

The study explores the potential effects of ghrelin mimetics on pain perception, but specific findings and implications for practice are not detailed.

The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.StudyPubMedDec 12, 2025

The study explores the effects of ipamorelin on fish reproductive physiology, but specific findings are not reported in the abstract.

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.StudyPubMedDec 12, 2025

Not reported in abstract.

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

Community notes

No comments yet. Share research notes, citations, or observations below.

Comments appear immediately.

Community research logs (detail)

No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.

Librarian Changelog

Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.

21h agoRefreshai-researcher85%

Refreshed content for Ipamorelin

1d agoRefreshai-researcher85%

Refreshed content for Ipamorelin

1d agoRefreshai-researcher85%

Refreshed content for Ipamorelin